Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
1,824.55
-1.95 (-0.11%)
Sep 6, 2024, 3:29 PM IST
SUNPHARMA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 492,088 | 484,969 | 438,857 | 386,545 | 334,981 | 328,375 | Upgrade
|
Revenue Growth (YoY) | 9.20% | 10.51% | 13.53% | 15.39% | 2.01% | 12.98% | Upgrade
|
Cost of Revenue | 113,594 | 114,422 | 113,187 | 108,761 | 92,185 | 96,796 | Upgrade
|
Gross Profit | 378,493 | 370,547 | 325,670 | 277,784 | 242,796 | 231,579 | Upgrade
|
Selling, General & Admin | 95,551 | 95,025 | 83,549 | 73,544 | 69,042 | 63,986 | Upgrade
|
Other Operating Expenses | 148,893 | 144,755 | 123,779 | 101,331 | 88,678 | 97,587 | Upgrade
|
Operating Expenses | 270,046 | 265,345 | 232,613 | 196,223 | 178,520 | 182,101 | Upgrade
|
Operating Income | 108,447 | 105,202 | 93,058 | 81,560 | 64,276 | 49,478 | Upgrade
|
Interest Expense | -2,191 | -2,385 | -1,720 | -1,274 | -1,414 | -3,027 | Upgrade
|
Interest & Investment Income | 11,262 | 11,262 | 5,310 | 7,687 | 4,672 | 4,108 | Upgrade
|
Earnings From Equity Investments | -417.6 | -384.1 | -479 | -165.4 | -123.3 | -148.3 | Upgrade
|
Currency Exchange Gain (Loss) | -163.6 | 361.3 | -1,261 | 1,540 | 236.5 | 156.1 | Upgrade
|
Other Non Operating Income (Expenses) | 4,852 | 1,571 | 756.5 | 735.9 | 2,895 | 1,828 | Upgrade
|
EBT Excluding Unusual Items | 121,788 | 115,627 | 95,664 | 90,084 | 70,542 | 52,394 | Upgrade
|
Merger & Restructuring Charges | -232.1 | -232.1 | -643.9 | -563.5 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -102 | -102 | -240.3 | 7.7 | 260 | 0.4 | Upgrade
|
Gain (Loss) on Sale of Assets | -99.7 | -99.7 | 75.4 | 347.5 | 138.8 | -52.2 | Upgrade
|
Asset Writedown | -72 | -1,564 | -312.5 | -2,179 | -155.5 | -1.5 | Upgrade
|
Legal Settlements | - | - | - | -1,563 | -895.6 | -1,043 | Upgrade
|
Other Unusual Items | -1,482 | -3,219 | -1,071 | -41,657 | -42,166 | -1,564 | Upgrade
|
Pretax Income | 119,885 | 110,495 | 93,605 | 44,648 | 27,870 | 49,948 | Upgrade
|
Income Tax Expense | 15,236 | 14,395 | 8,476 | 10,755 | 5,147 | 8,228 | Upgrade
|
Earnings From Continuing Operations | 104,649 | 96,100 | 85,129 | 33,893 | 22,724 | 41,720 | Upgrade
|
Minority Interest in Earnings | -754.3 | -336.5 | -393.6 | -1,166 | 6,315 | -4,070 | Upgrade
|
Net Income | 103,895 | 95,764 | 84,736 | 32,727 | 29,038 | 37,649 | Upgrade
|
Net Income to Common | 103,895 | 95,764 | 84,736 | 32,727 | 29,038 | 37,649 | Upgrade
|
Net Income Growth | 23.17% | 13.01% | 158.91% | 12.70% | -22.87% | 41.25% | Upgrade
|
Shares Outstanding (Basic) | 2,398 | 2,399 | 2,399 | 2,399 | 2,399 | 2,399 | Upgrade
|
Shares Outstanding (Diluted) | 2,398 | 2,399 | 2,399 | 2,399 | 2,399 | 2,399 | Upgrade
|
Shares Change (YoY) | -0.17% | - | - | - | - | 0.00% | Upgrade
|
EPS (Basic) | 43.32 | 39.91 | 35.32 | 13.64 | 12.10 | 15.69 | Upgrade
|
EPS (Diluted) | 43.31 | 39.90 | 35.30 | 13.60 | 12.10 | 15.69 | Upgrade
|
EPS Growth | 23.40% | 13.03% | 159.56% | 12.40% | -22.89% | 41.37% | Upgrade
|
Free Cash Flow | - | 99,332 | 28,738 | 74,895 | 50,002 | 50,128 | Upgrade
|
Free Cash Flow Per Share | - | 41.40 | 11.98 | 31.21 | 20.84 | 20.89 | Upgrade
|
Dividend Per Share | - | 13.500 | 11.500 | 10.000 | 7.500 | 4.000 | Upgrade
|
Dividend Growth | - | 17.39% | 15.00% | 33.33% | 87.50% | 45.45% | Upgrade
|
Gross Margin | 76.92% | 76.41% | 74.21% | 71.86% | 72.48% | 70.52% | Upgrade
|
Operating Margin | 22.04% | 21.69% | 21.20% | 21.10% | 19.19% | 15.07% | Upgrade
|
Profit Margin | 21.11% | 19.75% | 19.31% | 8.47% | 8.67% | 11.47% | Upgrade
|
Free Cash Flow Margin | - | 20.48% | 6.55% | 19.38% | 14.93% | 15.27% | Upgrade
|
EBITDA | 132,031 | 128,760 | 116,513 | 101,536 | 83,451 | 68,567 | Upgrade
|
EBITDA Margin | 26.83% | 26.55% | 26.55% | 26.27% | 24.91% | 20.88% | Upgrade
|
D&A For EBITDA | 23,584 | 23,559 | 23,456 | 19,975 | 19,175 | 19,089 | Upgrade
|
EBIT | 108,447 | 105,202 | 93,058 | 81,560 | 64,276 | 49,478 | Upgrade
|
EBIT Margin | 22.04% | 21.69% | 21.20% | 21.10% | 19.19% | 15.07% | Upgrade
|
Effective Tax Rate | 12.71% | 13.03% | 9.05% | 24.09% | 18.47% | 16.47% | Upgrade
|
Revenue as Reported | 508,911 | 498,510 | 445,202 | 395,760 | 343,337 | 334,735 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.